EUCTR2020-005149-18-AT进行中（未招募）1 期
Preclinical antiplatelet treatment with Cangrelor in patients presenting with ST-Elevation myocardial infarction: a randomized, double-blind, placebo-controlled pilot trial - Preclinical antiplatelet treatment with Cangrelor in STEMI
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with out-of-hospital ST-elevation myocardial infarction
- •male or non-pregnant female, aged between 18 and 74
- •hemodynamically stable, Killip class I
- •planned to undergo primary percutaneous coronary intervention (PCI)
- •PCI available < 120 min
- •pretreatment with morphine
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 32
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 32
排除标准
- •bodyweight < 50kg or > 99kg
- •known intolerance or allergy to cangrelor or another P2Y12 receptor inhibitor
- •active bleeding or increased risk of bleeding because of known coagulation or
- •platelet disorders
- •previous hemorrhagic stroke, under oral anticoagulant therapy, moderate to
- •severe liver disease
- •pregnancy or active breastfeeding
- •intake of clopidogrel, prasugrel or ticagrelor in the past 14 days
- •patient in a palliative setting OR life expectancy < 1 year
研究者
相似试验
进行中（未招募）
1 期
Platelet inhibition with cangrelor in unconcious survivors of out-of-hospital cardiac arrest undergoing cardiac artery stent implantatioComatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary interventionEUCTR2019-001285-15-SIniversity Medical Centre Ljubljana30
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGESubjects who present with an acute coronary syndrome.MedDRA version: 12.0Level: LLTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: PTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: LLTClassification code 10006894Term: CABGEUCTR2008-001135-35-CZThe Medicines Company220
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGEEUCTR2008-001135-35-GBThe Medicines Company220
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGEEUCTR2008-001135-35-NLThe Medicines Company220
已完成
2 期
Maintenance of platelet inhiBition with cangreloR after dIscontinuation of thienopyriDines in patients undergoing surGEry: The BRIDGE trialplatelet inhibition10011082NL-OMON34815Medicines Company50